Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder.
Wymer, Kevin M; Sharma, Vidit; Saigal, Christopher S; Chamie, Karim; Litwin, Mark S; Packiam, Vignesh T; Mossanen, Matthew; Pagliaro, Lance C; Borah, Bijan J; Boorjian, Stephen A.
Afiliación
  • Wymer KM; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Sharma V; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Saigal CS; Department of Urology, David Geffen School of Medicine; University of California, Los Angeles, California.
  • Chamie K; Greater Los Angeles VA, Health Services Research and Development Program, Los Angeles, California.
  • Litwin MS; Department of Urology, David Geffen School of Medicine; University of California, Los Angeles, California.
  • Packiam VT; Department of Urology, David Geffen School of Medicine; University of California, Los Angeles, California.
  • Mossanen M; Department of Urology, David Geffen School of Medicine; University of California, Los Angeles, California.
  • Pagliaro LC; Department of Health Policy and Management, Fielding School of Public Health; School of Nursing University of California, Los Angeles, California.
  • Borah BJ; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Boorjian SA; Division of Urologic Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
J Urol ; 205(5): 1326-1335, 2021 May.
Article en En | MEDLINE | ID: mdl-33347775
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma in Situ / Análisis Costo-Beneficio / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma in Situ / Análisis Costo-Beneficio / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article